- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/191 - Acyclic acids having two or more hydroxy groups, e.g. gluconic acid
Patent holdings for IPC class A61K 31/191
Total number of patents in this class: 637
10-year publication summary
|
52
|
52
|
57
|
71
|
60
|
58
|
62
|
49
|
40
|
37
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Exela Pharma Sciences, LLC | 24 |
20 |
| Neurocentria, Inc. | 32 |
18 |
| Gambro Lundia AB | 1398 |
13 |
| Innovation Technologies, Inc. | 30 |
9 |
| Gedea Biotech AB | 17 |
8 |
| Nusirt Sciences, Inc. | 41 |
6 |
| Replicon Health OY | 6 |
6 |
| Alpha Cognition Inc. | 21 |
6 |
| Vaginal Biome Science, Inc. | 16 |
6 |
| Société des Produits Nestlé S.A. | 10044 |
5 |
| Board of Supervisors of Louisiana State University and Agricultural and Mechanical College | 824 |
5 |
| Sonivie Ltd. | 38 |
5 |
| Fertin Pharma A/S | 286 |
5 |
| Centre National de La Recherche Scientifique | 11055 |
4 |
| Allergan Sales, LLC | 249 |
4 |
| Jazz Pharmaceuticals, Inc. | 131 |
4 |
| NxStage Medical, Inc. | 297 |
4 |
| Satiogen Pharmaceuticals, Inc. | 12 |
4 |
| SELO Medical GmbH | 29 |
4 |
| Pharmosa Biopharm Inc. | 22 |
4 |
| Other owners | 497 |